Key result
Coordinated CKM care requires holistic multi-drug therapy, but fragmented care limits real-world implementation.
Why the study?
Effective management of cardiovascular-kidney-metabolic syndrome is limited by fragmented care, limited awareness, socioeconomic inequalities, and a persistent risk treatment paradox.
Answers are grounded in this paper and cite their sources.
Comprehensive management of cardiovascular-kidney-metabolic syndrome requires a holistic, multiorgan approach integrating novel pharmacotherapies and addressing structural barriers to care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Balfanz et al. (2026) conducted a review in Cardiovascular-kidney-metabolic (CKM) syndrome. Holistic treatment strategies was evaluated. Cardiovascular-kidney-metabolic syndrome management requires coordinated holistic interventions, though fragmented care and socioeconomic inequalities continue to limit implementation.
Synapse has enriched 10 related papers. Consider them for comparative context: